about
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B.Efficacy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (VONCENTO®) in subjects with haemophilia A (SWIFT-HA study).Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B.Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia
P50
Q33385646-307B7247-2AA3-48B7-BE54-7F6C220AD933Q33418036-408E2A9E-2225-4903-A7D8-0E7625DE64D8Q33886162-507E3ED7-A516-40D7-92F3-212AE1A8483AQ39635163-47BACC38-3EA3-4FF1-B4E7-209211A320C3Q45855778-027A8812-D370-4A69-9EFA-42F3E01904C6Q45881158-413DDB8E-F8D6-47BB-B127-08D52DAB8BCEQ45887347-00D2F4E8-BC1B-447D-AFF7-A15807DC2699Q55056539-BB65E444-C90D-424B-A422-89C2F4B61534Q81599934-6BCBAD4C-049B-4A52-8289-DA751853E01D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Liana Gercheva
@ast
Liana Gercheva
@en
Liana Gercheva
@es
Liana Gercheva
@nl
type
label
Liana Gercheva
@ast
Liana Gercheva
@en
Liana Gercheva
@es
Liana Gercheva
@nl
prefLabel
Liana Gercheva
@ast
Liana Gercheva
@en
Liana Gercheva
@es
Liana Gercheva
@nl
P106
P1153
6506344705
P31
P496
0000-0002-5323-3241